esorubicin has been researched along with Cancer of Liver in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cnaan, A; Dayal, Y; Falkson, G; Falkson, H; Haller, DG; Simson, IW; Smith, TJ | 1 |
| Mick, R; Perry, DJ; Van Echo, DA | 1 |
| Aronne, T; Codacci Pisanelli, G; D'Amelio, R; Franchi, F; Manfredi, D; Mulieri, M; Seminara, P | 1 |
1 trial(s) available for esorubicin and Cancer of Liver
| Article | Year |
|---|---|
A randomized phase II study of acivicin and 4'deoxydoxorubicin in patients with hepatocellular carcinoma in an Eastern Cooperative Oncology Group study.
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Doxorubicin; Drug Administration Schedule; Female; Humans; Isoxazoles; Liver Neoplasms; Male; Prospective Studies; Survival Rate | 1990 |
2 other study(ies) available for esorubicin and Cancer of Liver
| Article | Year |
|---|---|
Phase II study of deoxydoxorubicin in patients with advanced liver cancer.
Topics: Adult; Antibiotics, Antineoplastic; Diagnosis-Related Groups; Doxorubicin; Drug Evaluation; Female; Humans; Liver Neoplasms; Male; Middle Aged | 1987 |
Anthracycline in colorectal carcinoma: an in vitro short-term assay to predict drug sensitivity. Preliminary results.
Topics: Colonic Neoplasms; DNA, Neoplasm; Doxorubicin; Drug Evaluation, Preclinical; Drug Resistance; Epirubicin; Humans; In Vitro Techniques; Liver Neoplasms; Rectal Neoplasms; RNA, Neoplasm | 1987 |